In the case of British Columbia v McKinsey dated October 12, 2023, the representative plaintiff, His Majesty the King in Right of the Province of British Columbia (referred to as "the Province"), initiated legal proceedings to recover opioid-related healthcare costs and damages on behalf of various Canadian governments. These efforts included two sets of actions, with the second one in question. The main action, known as the "M&D Action," targeted manufacturers and distributors involved in opioid drugs and products. It was brought under specific legislation, the Opioid Damages and Health Care Costs Recovery Act, and the Class Proceedings Act. This action was progressing toward a certification hearing in late 2023. The current matter involved defendant McKinsey's application to strike certain claims made in the Amended Notice of Civil Claim (ANCC) in the McKinsey Action. McKinsey argued that the Province's claims lacked sufficient detail and failed to connect McKinsey to the alleged wrongdoing and its impact on British Columbia. The Province contended that there was a meaningful connection and resisted the application. Ultimately, the motion to strike the ANOCC was dismissed, allowing the Province to amend its claim as per the provided reasons. No specific information regarding a financial award had been provided in the case.